Cytodyn Inc (CYDY)

[Apollo_]

CytoDyn, Inc (CYDY) Shares Surpass Important Resistance Level

"The last time shares were above this important $1.00 resistance level was last year, when stock reached $1.50 in October. A good amount of trading volume (currently at 160,000 shares) may maintain these levels and push the stock higher....

There is no question that the market for immune deficiency viruses is a massive one. A breakthrough in innovative therapies is what CytoDyn’s team is striving to achieve.

CYDY shares haven’t traded below $0.50 since 2009, which proves that the stock has some sustainability above this level.

Trial and error phase is an inherent reality of the biotechnology sector. Not knowing if clinical trials will obtain expected results is part of an investor’s risk/reward bet on the company’s stock.

However, the movement we have seen since June cannot be taken for granted and could represent a breakthrough performance for CYDY."

http://www.superstockprofits.com/news/245-cytodyn-inc-cydy-shares-surpass-important-resistance-level#.U6NvGbvn-P9